JOHNSON & JOHNSON revenue breakdown overview

JOHNSON & JOHNSON revenue for the last year amounted to 80.67 B CHF, the most of which — 51.73 B CHF — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 46.10 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON 45.68 B CHF, and the year before that — 39.10 B CHF.